Terms: = Ovarian cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Prognosis
16 results:
1. Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival.
Ye S; Zhou S; Wu Y; Pei X; Jiang W; Shi W; Yang W; Zhou X; Shan B; Yang H
Ann Med; 2023 Dec; 55(1):2218104. PubMed ID: 37272300
[TBL] [Abstract] [Full Text] [Related]
2. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
[TBL] [Abstract] [Full Text] [Related]
3. The value of SOX2 in the differential diagnosis of smarca4 (brg1)-deficient uterine neoplasms.
Zheng L; Zhang L; Wang XI; Katz G; Tandon N; Zhao B; Lucci J; Ding J; Zhang S
Hum Pathol; 2022 Jun; 124():45-55. PubMed ID: 35331811
[TBL] [Abstract] [Full Text] [Related]
4. Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (ovarian Rhabdoid Tumor) with
Simões MFE; da Costa AABA; Silva TN; Fernandes L; Bovolim G; Torrezan GT; Carraro DM; Baiocchi G; Menezes ANO; Santana Dos Santos E; De Brot L
Curr Oncol; 2022 Jan; 29(2):411-422. PubMed ID: 35200537
[TBL] [Abstract] [Full Text] [Related]
5. smarca4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca
Xue Y; Morris JL; Yang K; Fu Z; Zhu X; Johnson F; Meehan B; Witkowski L; Yasmeen A; Golenar T; Coatham M; Morin G; Monast A; Pilon V; Fiset PO; Jung S; Gonzalez AV; Camilleri-Broet S; Fu L; Postovit LM; Spicer J; Gotlieb WH; Guiot MC; Rak J; Park M; Lockwood W; Foulkes WD; Prudent J; Huang S
Nat Commun; 2021 Sep; 12(1):5404. PubMed ID: 34518526
[TBL] [Abstract] [Full Text] [Related]
6. ovarian carcinoma in children with constitutional mutation of smarca4: single-family report and literature review.
Pastorczak A; Krajewska K; Urbanska Z; Szmyd B; Salacinska-Los E; Kobos J; Mlynarski W; Trelinska J
Fam Cancer; 2021 Oct; 20(4):355-362. PubMed ID: 33907931
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of SWI/SNF Protein Expression by Immunohistochemistry in ovarian Clear Cell Carcinoma.
Bennett JA; Safdar N; Segal JP; Lastra RR; Oliva E
Int J Gynecol Pathol; 2021 Mar; 40(2):156-164. PubMed ID: 32897960
[TBL] [Abstract] [Full Text] [Related]
8. Small Cell Carcinoma of the Ovary: Clinicopathologic and Immunohistochemical Analysis of 7 New Cases of a Rare Malignancy.
Gupta P; Kapatia G; Gupta N; Dey P; Rohilla M; Gupta A; Rai B; Suri V; Rajwanshi A; Srinivasan R
Int J Surg Pathol; 2021 May; 29(3):236-245. PubMed ID: 32772748
[TBL] [Abstract] [Full Text] [Related]
9. SWI/SNF protein and claudin-4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum.
Chaudet K; Kem M; Lerwill M; Young RH; Mino-Kenudson M; Agaimy A; McCluggage WG; Oliva E
Histopathology; 2020 Aug; 77(2):231-239. PubMed ID: 32268438
[TBL] [Abstract] [Full Text] [Related]
10. Small Cell Carcinoma of Ovary, Hypercalcemic Type (Malignant Rhabdoid Tumor of Ovary) with Loss of smarca4 (brg1) Expression: Report of Two Cases.
Sahay A; Kante K; Menon S; Ghosh J; Kerkar RA; Deodhar KK
Turk Patoloji Derg; 2020; 1(1):261-267. PubMed ID: 32149361
[TBL] [Abstract] [Full Text] [Related]
11. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract] [Full Text] [Related]
12. SWI/SNF-Compromised cancers Are Susceptible to Bromodomain Inhibitors.
Shorstova T; Marques M; Su J; Johnston J; Kleinman CL; Hamel N; Huang S; Alaoui-Jamali MA; Foulkes WD; Witcher M
Cancer Res; 2019 May; 79(10):2761-2774. PubMed ID: 30877105
[TBL] [Abstract] [Full Text] [Related]
13. Loss of smarca4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.
Conlon N; Silva A; Guerra E; Jelinic P; Schlappe BA; Olvera N; Mueller JJ; Tornos C; Jungbluth AA; Young RH; Oliva E; Levine D; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):395-403. PubMed ID: 26645725
[TBL] [Abstract] [Full Text] [Related]
14. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.
Callegaro-Filho D; Gershenson DM; Nick AM; Munsell MF; Ramirez PT; Eifel PJ; Euscher ED; Marques RM; Nicolau SM; Schmeler KM
Gynecol Oncol; 2016 Jan; 140(1):53-7. PubMed ID: 26546963
[TBL] [Abstract] [Full Text] [Related]
15. ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder.
Faraj SF; Chaux A; Gonzalez-Roibon N; Munari E; Ellis C; Driscoll T; Schoenberg MP; Bivalacqua TJ; Shih IeM; Netto GJ
Hum Pathol; 2014 Nov; 45(11):2233-9. PubMed ID: 25175170
[TBL] [Abstract] [Full Text] [Related]
16. In vitro and in vivo therapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model.
Otte A; Rauprich F; Hillemanns P; Park-Simon TW; von der Ohe J; Hass R
Orphanet J Rare Dis; 2014 Aug; 9():126. PubMed ID: 25103190
[TBL] [Abstract] [Full Text] [Related]
